PUBLICATIONS
Integrating the multiple breath washout test into international multicentre trials
Clare Saunders, Renee Jensen, Paul D. Robinson, Sanja Stanojevic, Michelle Klingel, Christopher Short, Jane C. Davies, Felix Ratjen
A Short extension to multiple breath washout provides additional signal of distal airway disease in people with CF: A pilot study
Christopher Short , Thomas Semple, Clare Saunders , Dominic Hughes , Samantha Irving , Laura Gardener, Mark Rosenthal , Paul D Robinson, Jane C Davies
https://doi.org/10.1016/j.jcf.2021.06.013
Evaluation of a multiple breath nitrogen washout system in children
Sarah Issac, Renee Jensen, Pinelopi Anagnostopoulou, Jane C. Davies, Monika Gappa, Phillip Latzin, Clare Saunders, Christopher Short, Florian Singer, Sanja Stanjevic, Annelies Zwitseroot, Felix Ratjen
Horses for courses: Learning from functional tests of pulmonary health?
Developments in multiple breath washout testing in children with cystic fibrosis
Clare Saunders, Katie Bayfield, Samantha Irving, Christopher Short, Andrew Bush, Jane C. Davies
A phase 3, double-blind, parallel-group study to evaluate the efficacy and safety of tezacaftor in combination with ivacaftor in participants 6 through 11 years of age with cystic fibrosis homozygous for F508del or heterozygous for the F508del-CFTR mutation and a residual function mutation
Jane C. Davies, Isabelle Sermet-Gaudelus, Lutz Naehrlich, R. Scott Harris, Daniel Campbell, Neil Ahluwalia, Christopher Short, Eric Haseltine, Paul Panorchan, Clare Saunders, Caroline A. Owen, Claire E. Wainwright, VX16-661-115 Investigator Group
Ivacaftor in People With Cystic Fibrosis and a 3849+10kb C →T or D1152H Residual Function Mutation
Eitan Kerem, Malena Cohen- Cymberknoh, Reuven Tsabari, Michael Wilschanski, Joel Reiter, David Shoseyov, Alex Gileles-Hillel, Thea Pugastch, Jane C. Davies, Christopher Short, Clare Saunders, Cynthia DeSouza, James C. Sullivan, Jamie R. Doyle, Keval Chandarana, Nils Kinnman
Utility of lung clearance index in CF: What we know, what we don't know and musings on how to bridge the gap
Christopher Short, Clare Saunders, Jane C. Davies
Multiple breath washout in bronchiectasis clinical trials: is it feasible?
Katherine O'Neill, Kathryn Ferguson, Denis Cosgrove, Michael M. Tunney, Anthony De Soyza, Mary Carroll, James D. Chalmers, Timothy Gatheral, Adam T. Hill, John R. Hurst, Christopher Johnson, Michael R. Loebinger, Gerhild Angyalosi, Charles S. Haworth, Renee Jensen, Felix Ratjen, Clare Saunders, Christopher Short, Jane C. Davies, J. Stuart Elborn, Judy M. Bradley
Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial
Felix Ratjen, Christopher Hug, Gautham Marigowda , Simon Tian, Xiaohong Huang, Sanja Stanojevic, Carlos E Milla, Paul D Robinson. David Waltz, Jane C Davies, VX14-809-109 investigator group
Entering the era of highly effective modulator therapies
Kavita Dave, Rebecca Dobra, Sandra Scott, Clare Saunders, Jess Matthews, Nicholas J. Simmonds, Jane C. Davies
Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation
Alex R Horsley, Jane C Davies, Robert D Gray, Kenneth A Macleod, Jackie Donovan, Zelena A Aziz, Nicholas J Bell, Margaret Rainer, Shahrul Mt-Isa, Nia Voase, Maria H Dewar, Clare Saunders, James S Gibson, Javier Parra-Leiton, Mia D Larsen, Sarah Jeswiet, Samia Soussi, Yusura Bakar, Mark G Meister, Philippa Tyler, Ann Doherty, David M Hansell, Deborah Ashby, Stephen C Hyde, Deborah R Gill, Andrew P Greening, David J Porteous, J Alastair Innes, A Christopher Boyd, Uta Griesenbach, Steve Cunningham, Eric WFW Alton
Guiding the rational design of patient-centred drug trials in Cystic Fibrosis: A Delphi study
Rebecca Dobra, Stewart J. Elborn, Susan L. Madge, Lorna Allen, Marco Boeri, S Goundry, T Purcell, Clare Saunders, Jane C. Davies